LDN-212854 is a novel BMP inhibitor that exhibits substantially greater selectivity for BMP versus the TGF-¦Â type I receptors; possesses a bias towards ALK2(IC50=1.3 nM) versus ALK1 and ALK3 compared to other inhibitors.

June 21, 2017

prudect name : LDN-212854 is a novel BMP inhibitor that exhibits substantially greater selectivity for BMP versus the TGF-¦Â type I receptors; possesses a bias towards ALK2(IC50=1.3 nM) versus ALK1 and ALK3 compared to other inhibitors.
LDN-212854

Synonyms: CAS NO: 1432597-26-6Molecular Formula: C₂₅H₂₂N₆Molecular Weight: 406.48Purity: 98% minSolubility: In DMSOStorage: -20 oC

VX 497 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18523958